Active Ingredient History

NOW
  • Now
Clodronic acid (INN) or clodronate disodium (Na2CH2Cl2O6P2) (USAN) is a first generation (non-nitrogenous) bisphosphonate. It is an anti-osteoporotic drug approved for the prevention and treatment of osteoporosis in post-menopausal women and men to reduce vertebral fractures, hyperparathyroidism, hypercalcemia in malignancy, multiple myeloma and fracture related pain because of its anti-inflammatory effects shown as a reduction in inflammatory markers like IL-1β, IL-6, and TNF-α.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
177501 | acide clodronique | acido clodronico | acidum clodronicum | bonefos | clodronate | clodronate disodium | clodronic acid | clodronsaeure | clodronsäure | dichloromethanediphosphonic acid | dichloromethylene-1,1-bisphosphonic acid | dichloromethylene-1,1-diphosphonic acid | (dichloromethylene)bisphosphonic acid | (dichloromethylene)diphosphonic acid | dichloromethylenediphosphonic acid | dichloromethylidene diphosphonate | (dichloro-phosphono-methyl)-phosphonic acid | disodium clodronate | methanedichlorodiphosphonic acid | zk-00091106

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue